Related references
Note: Only part of the references are listed.Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation
David Croteau et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Clinical and Radiologic Features, Pathology, and Treatment of Balo Concentric Sclerosis
Evan A. Jolliffe et al.
NEUROLOGY (2021)
A tumefactive demyelinating lesion in a person with MS after five years of fingolimod
L. Jeung et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
From Balo's concentric sclerosis to multiple sclerosis: a series of 6 patients
Xavier Ayrignac et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Heterogeneity of Balo's concentric sclerosis: a study of eight cases with different therapeutic concepts
D. Tzanetakos et al.
BMC NEUROLOGY (2020)
Balo's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures
S. Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Balo's concentric sclerosis: an update and comprehensive literature review
Ali Amini Harandi et al.
REVIEWS IN THE NEUROSCIENCES (2018)
7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions
Janina R. Behrens et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Atypical inflammatory demyelinating syndromes of the CNS
Todd A. Hardy et al.
LANCET NEUROLOGY (2016)
Bal's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Anna M. Pietroboni et al.
NEUROLOGICAL SCIENCES (2015)
First use of alemtuzumab in Balo's concentric sclerosis: a case report
J. W. L. Brown et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Balo's Concentric Sclerosis in Multiple Sclerosis
Barbara Barun et al.
INTERNAL MEDICINE (2012)
Vanishing Balo-like lesions in multiple sclerosis
G Iannucci et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)